PSGRX
Price
$62.72
Change
-$0.08 (-0.13%)
Updated
Apr 25 closing price
Net Assets
2.64B
VSGIX
Price
$69.55
Change
+$0.16 (+0.23%)
Updated
Apr 25 closing price
Net Assets
33.7B
Ad is loading...

PSGRX vs VSGIX

Header iconPSGRX vs VSGIX Comparison
Open Charts PSGRX vs VSGIXBanner chart's image
Putnam Small Cap Growth R
Price$62.72
Change-$0.08 (-0.13%)
VolumeN/A
Net Assets2.64B
Vanguard Small Cap Growth Index I
Price$69.55
Change+$0.16 (+0.23%)
VolumeN/A
Net Assets33.7B
PSGRX vs VSGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PSGRX vs. VSGIX commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSGRX is a Buy and VSGIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 33.7B vs. PSGRX (2.64B). VSGIX pays higher dividends than PSGRX: VSGIX (0.61) vs PSGRX (0.00). PSGRX was incepted earlier than VSGIX: PSGRX (21 years) vs VSGIX (25 years). PSGRX (1.46) is less costly to investors than VSGIX (0.06). PSGRX is a more actively managed with annual turnover of: 40.00 vs. VSGIX (19.00). PSGRX has a lower initial minimum investment than VSGIX: PSGRX (0) vs VSGIX (5000000). PSGRX annual gain was more profitable for investors over the last year : 2.77 vs. VSGIX (1.56). VSGIX (48.63) and PSGRX (47.14) have equivalent 5 years return.
PSGRXVSGIXPSGRX / VSGIX
Total Expense Ratio1.460.062,433%
Annual Report Gross Expense Ratio1.460.062,433%
Fund Existence21 years25 years-
Gain YTD-9.038-11.93976%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.64B33.7B8%
Annual Yield % from dividends0.000.61-
Returns for 1 year2.771.56177%
Returns for 3 years29.7310.75276%
Returns for 5 years47.1448.6397%
Returns for 10 years101.7388.13115%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DREQX18.22N/A
N/A
BNY Mellon Research Growth Z
LAFCX18.26N/A
N/A
Lord Abbett Affiliated C
LGOQX20.51N/A
N/A
Lord Abbett Growth Opportunities R2
DHIYX17.99N/A
N/A
Diamond Hill International Y
ESCGX10.08N/A
N/A
Ashmore Emerging Markets Equity ESG C